Found: 17
Select item for more details and to access through your institution.
A Review of Obinutuzumab (GA101), a Novel Type II Anti-CD20 Monoclonal Antibody, for the Treatment of Patients with B-Cell Malignancies.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Macrophage-derived, macrophage migration inhibitory factor (MIF) is necessary to induce disease in the K/BxN serum-induced model of arthritis.
- Published in:
- Rheumatology International, 2013, v. 33, n. 9, p. 2301, doi. 10.1007/s00296-013-2713-4
- By:
- Publication type:
- Article
Mode of progression after first line treatment correlates with outcome of chronic lymphocytic leukemia (CLL).
- Published in:
- American Journal of Hematology, 2019, v. 94, n. 9, p. 1002, doi. 10.1002/ajh.25561
- By:
- Publication type:
- Article
Brain Miffed by Macrophage Migration Inhibitory Factor.
- Published in:
- International Journal of Cell Biology, 2012, p. 1, doi. 10.1155/2012/139573
- By:
- Publication type:
- Article
Role of Migratory Inhibition Factor in Age-Related Susceptibility to Radiation Lung Injury via NF-E2-Related Factor-2 and Antioxidant Regulation.
- Published in:
- American Journal of Respiratory Cell & Molecular Biology, 2013, v. 49, n. 2, p. 269, doi. 10.1165/rcmb.2012-0291OC
- By:
- Publication type:
- Article
Macrophage migration inhibitory factor promotes renal injury induced by ischemic reperfusion.
- Published in:
- Journal of Cellular & Molecular Medicine, 2019, v. 23, n. 6, p. 3867, doi. 10.1111/jcmm.14234
- By:
- Publication type:
- Article
Sequential chemoimmunotherapy of fludarabine, mitoxantrone, and cyclophosphamide induction followed by alemtuzumab consolidation is effective in T-cell prolymphocytic leukemia.
- Published in:
- Cancer (0008543X), 2013, v. 119, n. 12, p. 2258, doi. 10.1002/cncr.27972
- By:
- Publication type:
- Article
MIF coordinates the cell cycle with DNA damage checkpoints. Lessons from knockout mouse models.
- Published in:
- Cell Division, 2007, v. 2, p. 22, doi. 10.1186/1747-1028-2-22
- By:
- Publication type:
- Article
Monoklonale Antikörper bei Lymphomen.
- Published in:
- Drug Research / Arzneimittel-Forschung (Editio Cantor Verlag fur Medizin und Naturwissenschaften), 2005, v. 55, n. 11, p. 704
- By:
- Publication type:
- Article
Macrophage Migration Inhibitory Factor Enzymatic Activity, Lung Inflammation, and Cystic Fibrosis.
- Published in:
- American Journal of Respiratory & Critical Care Medicine, 2012, v. 186, n. 2, p. 162, doi. 10.1164/rccm.201110-1864oc
- By:
- Publication type:
- Article
Macrophage migration inhibitory factor (MIF) and its homolog D-dopachrome tautomerase (D-DT) are significant promotors of UVB- but not chemically induced non-melanoma skin cancer.
- Published in:
- Scientific Reports, 2023, v. 13, n. 1, p. 1, doi. 10.1038/s41598-023-38748-9
- By:
- Publication type:
- Article
Pharmacokinetics, exposure, efficacy and safety of obinutuzumab in rituximab‐refractory follicular lymphoma patients in the GADOLIN phase III study.
- Published in:
- British Journal of Clinical Pharmacology, 2019, v. 85, n. 9, p. 1935, doi. 10.1111/bcp.13974
- By:
- Publication type:
- Article
Role of obinutuzumab exposure on clinical outcome of follicular lymphoma treated with first‐line immunochemotherapy.
- Published in:
- British Journal of Clinical Pharmacology, 2019, v. 85, n. 7, p. 1495, doi. 10.1111/bcp.13920
- By:
- Publication type:
- Article
The Outcome of Renal Ischemia-Reperfusion Injury Is Unchanged in AMPK-β1 Deficient Mice.
- Published in:
- PLoS ONE, 2012, v. 7, n. 1, p. 1, doi. 10.1371/journal.pone.0029887
- By:
- Publication type:
- Article
MIF is a noncognate ligand of CXC chemokine receptors in inflammatory and atherogenic cell recruitment.
- Published in:
- Nature Medicine, 2007, v. 13, n. 5, p. 587, doi. 10.1038/nm1567
- By:
- Publication type:
- Article
Macrophage Migration Inhibitory Factor Inhibits the Antiinflammatory Effects of Glucocorticoids via Glucocorticoid-Induced Leucine Zipper.
- Published in:
- Arthritis & Rheumatology, 2014, v. 66, n. 8, p. 2059, doi. 10.1002/art.38689
- By:
- Publication type:
- Article
The vestigial enzyme D-dopachrome tautomerase protects the heart against ischemic injury.
- Published in:
- Journal of Clinical Investigation, 2014, v. 124, n. 8, p. 3540, doi. 10.1172/JCI73061
- By:
- Publication type:
- Article